Arianne M. Babina

Arianne M. Babina

Auto-generated profile, based on publicly available information

Arianne M. Babina

Department of Medical Biochemistry and Microbiology, Uppsala University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
MKMichael Knopp
Michael Knopp
ABArianne M. Babina
Arianne M. Babina
JGJónína S. Gudmundsdóttir
Jónína S. Gudmundsdóttir
MDMartin V. Douglass
Martin V. Douglass
MTM. Stephen Trent
M. Stephen Trent
DADan I. Andersson
Dan I. Andersson
Antibiotic resistance is a rapidly increasing medical problem that severely limits the success of antibiotic treatments, and the identification of resistance determinants is key for surveillance and control of resistance dissemination. Horizontal transfer is the dominant mechanism for spread of resistance genes between bacteria but little is known about the original emergence of resistance genes. Here, we examined experimentally if random sequences can generate novel antibiotic resistance determinants de novo. By utilizing highly diverse expression libraries encoding random sequences to select for open reading frames that confer resistance to the last-resort antibiotic colistin in Escherichia coli, six de novo colistin resistance conferring peptides (Dcr) were identified. The peptides act via direct interactions with the sensor kinase PmrB (also termed BasS in E. coli), causing an activation of the PmrAB two-component system (TCS), modification of the lipid A domain of lipopolysaccharide and subsequent colistin resistance. This kinase-activation was extended to other TCS by generation of chimeric sensor kinases. Our results demonstrate that peptides with novel activities mediated via specific peptide-protein interactions in the transmembrane domain of a sensory transducer can be selected de novo, suggesting that the origination of such peptides from non-coding regions is conceivable. In addition, we identified a novel class of resistance determinants for a key antibiotic that is used as a last resort treatment for several significant pathogens. The high-level resistance provided at low expression levels, absence of significant growth defects and the functionality of Dcr peptides across different genera suggest that this class of peptides could potentially evolve as bona fide resistance determinants in natura.

15 March 2023 in eLife
Verified
Journal Article
Open access
ABArianne M Babina
Arianne M Babina
SSSerhiy Surkov
Serhiy Surkov
WYWeihua Ye
Weihua Ye
JJJon Jerlström-Hultqvist
Jon Jerlström-Hultqvist
MLMårten Larsson
Mårten Larsson
MKMichael Knopp
Michael Knopp
Increasing numbers of small proteins with diverse physiological roles are being identified and characterized in both prokaryotic and eukaryotic systems, but the origins and evolution of these proteins remain unclear. Recent genomic sequence analyses in several organisms suggest that new functions encoded by small open reading frames (sORFs) may emerge de novo from noncoding sequences. However, experimental data demonstrating if and how randomly generated sORFs can confer beneficial effects to cells are limited. Here, we show that by upregulating hisB expression, de novo small proteins (≤50 amino acids in length) selected from random sequence libraries can rescue Escherichia coli cells that lack the conditionally essential SerB enzyme. The recovered small proteins are hydrophobic and confer their rescue effect by binding to the 5′ end regulatory region of the his operon mRNA, suggesting that protein binding promotes structural rearrangements of the RNA that allow increased hisB expression. This study adds RNA regulatory elements as another interacting partner for de novo proteins isolated from random sequence libraries and provides further experimental evidence that small proteins with selective benefits can originate from the expression of nonfunctional sequences.

30 April 2024 in RNA
Verified
Journal Article
Open access
PDF file
ABArianne M. Babina
Arianne M. Babina
LKLeif Kirsebom
Leif Kirsebom
DADan I. Andersson
Dan I. Andersson
RNase P is an essential enzyme found across all domains of life that is responsible for the 5′-end maturation of precursor tRNAs. For decades, numerous studies have sought to elucidate the mechanisms and biochemistry governing RNase P function. However, much remains unknown about the regulation of RNase P expression, the turnover and degradation of the enzyme, and the mechanisms underlying the phenotypes and complementation of specific RNase P mutations, especially in the model bacterium,Escherichia coli. InE. coli, the temperature-sensitive (ts)rnpA49mutation in the protein subunit of RNase P has arguably been one of the most well-studied mutations for examining the enzyme's activity in vivo. Here, we report for the first time naturally occurring temperature-resistant suppressor mutations ofE. colistrains carrying thernpA49allele. We find thatrnpA49strains can partially compensate the ts defect via gene amplifications of either RNase P subunit (rnpA49orrnpB) or by the acquisition of loss-of-function mutations in Lon protease or RNase R. Our results agree with previous plasmid overexpression and gene deletion complementation studies, and importantly suggest the involvement of Lon protease in the degradation and/or regulatory pathway(s) of the mutant protein subunit of RNase P. This work offers novel insights into the behavior and complementation of thernpA49allele in vivo and provides direction for follow-up studies regarding RNase P regulation and turnover inE. coli.

5 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ABArianne M. Babina
Arianne M. Babina
LKLeif Kirsebom
Leif Kirsebom
DADan I. Andersson
Dan I. Andersson
RNase P is an essential enzyme found across all domains of life that is responsible for the 5’-end maturation of precursor tRNA transcripts. Since its discovery in the 1970s, numerous studies have sought to elucidate the mechanisms and biochemistry governing RNase P function. However, much remains unknown about the regulation of RNase P expression, the turnover and degradation of the enzyme, and the mechanisms underlying the phenotypes and complementation of specific RNase P mutations. In Escherichia coli , the temperature-sensitive rnpA49 mutation in the protein subunit of RNase P has arguably been one of the most well-studied and commonly used mutations for examining the enzyme’s activity in vivo . Here we report for the first time naturally-occurring temperature-resistant suppressor mutations of E. coli strains carrying the rnpA49 allele. We find that rnpA49 strains can partially compensate the temperature-sensitive defect via gene amplifications of either RNase P subunit ( rnpA49 or rnpB ) or by the acquisition of loss-of-function mutations in Lon protease or RNase R. Our results agree with previous plasmid overexpression and gene deletion complementation studies and importantly suggest the involvement of Lon protease in the degradation and/or regulatory pathway(s) of the mutant protein subunit of RNase P. This work offers novel insight into the behavior and complementation of the rnpA49 allele in vivo and provides direction for follow-up studies regarding RNase P regulation and turnover.

15 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ABArianne M. Babina
Arianne M. Babina
SSSerhiy Surkov
Serhiy Surkov
WYWeihua Ye
Weihua Ye
JJJon Jerlström-Hultqvist
Jon Jerlström-Hultqvist
MLMårten Larsson
Mårten Larsson
MKMichael Knopp
Michael Knopp
Increasing numbers of small proteins with diverse physiological roles are being identified and characterized in both prokaryotic and eukaryotic systems, but the origins and evolution of these proteins remain unclear. Recent genomic sequence analyses in several organisms suggest that new functions encoded by small open reading frames (sORFs) may emerge de novo from noncoding sequences. However, experimental data demonstrating if and how randomly generated sORFs can confer beneficial effects to cells are limited. Here we show that by up-regulating hisB expression, de novo small proteins (≤ 50 amino acids in length) selected from random sequence libraries can rescue Escherichia coli cells that lack the conditionally essential SerB enzyme. The recovered small proteins are hydrophobic and confer their rescue effect by binding to the 5’ end regulatory region of the his operon mRNA, suggesting that protein binding promotes structural rearrangements of the RNA that allow increased hisB expression. This study adds RNA regulatory elements as another interacting partner for de novo proteins isolated from random sequence libraries, and provides further experimental evidence that small proteins with selective benefits can originate from the expression of nonfunctional sequences.